Breast cancer research stamp

Last updated
1998 USPS Breast Cancer research semi-postal Stamp Stamp-USPS 1998 Breast Cancer Research semi-postal.jpg
1998 USPS Breast Cancer research semi-postal Stamp

The breast cancer research stamp (BCRS) is a semi-postal non-denominated postage stamp issued by the United States Postal Service, priced in 2011 as eleven cents higher than the standard first-class letter rate. The surplus above the price of the first-class stamp is collected by the United States Postal Service (USPS) and allocated to the National Institutes of Health (NIH) and the Department of Defense (DoD) for breast cancer research.

Contents

Originally created in 1997, Congress has reauthorized the Breast Cancer Research Stamp several times. The original sponsors for the bill were United States Senators Dianne Feinstein (D-CA), Alfonse D’Amato (R-NY), and Lauch Faircloth (R-NC), and United States Representatives Vic Fazio (D-CA) and Susan Molinari (R-NY). Breast cancer surgeon, Ernie Bodai, breast cancer survivor and advocate, Betsy Mullen, and breast cancer advocate David Goodman who lost his first wife to breast cancer, spearheaded the grassroots advocacy efforts in partnership with Senator Feinstein and her colleagues that led to the creation and issuance of this historic stamp designed to save lives.

The hugely successful Breast Cancer Research Stamp is an example of conscientious consumption in cause marketing, in which a person substitutes buying and consuming along with a tiny donation, for making a more significant donation. [1]

History and description

In 1996, the United States Postal Service Breast Cancer Awareness Stamp (the pink ribbon stamp at the then-current first class rate of 32 cents) was issued and did not sell well.

The Breast Cancer Research Stamp was the idea of Ernie Bodai, MD, a breast surgeon. In 1997 he approached the United States Postal Service about pricing a stamp a few pennies over the regular price with the extra pennies to be used for breast cancer research. He was turned away. [2] Dr. Bodai is a Kaiser Permanente surgeon who performs lumpectomies and mastectomies on women with breast cancer. Betsy Mullen is a breast cancer survivor and advocate, the Founder of WIN Against Breast Cancer and the Breast Buddy Breast Care Program. Dr. Bodai, Betsy Mullen and David Goodman spent their money and time lobbying for Congress' approval of the Breast Cancer Research Stamp. Dr. Bodai later began a nonprofit organization, Cure Breast Cancer Inc., to raise money to bring attention to the BCR Stamp and the breast cancer cause.

In 1995, in the U.S. House of Representatives Committee on Appropriations, Treasury, Postal Subcommittee New York Congressman Michael Forbes attached language to the annual spending bill mandating a Breast Cancer Research Stamp be created by the United States Postal Service (USPS). Proceeds above the cost of the semipostal (fundraising) stamp were to be dedicated to breast cancer research.

In 1998, United States Senators Dianne Feinstein, Alfonse D'Amato, and Lauch Faircloth and Congressman Vic Fazio sponsored legislation in the United States Congress to create a stamp where a portion of the proceeds of sale would go toward breast cancer research, creating the Breast Cancer Research Stamp. The legislation mandated that 70% of funds raised would go to the National Cancer Institute (NCI) and 30% would go to the Breast Cancer Research Program of the Department of Defense (DOD). [3]

Art director Ethel Kessler, of Bethesda, Maryland, herself a breast cancer survivor, [4] was asked by the USPS to design the new stamp. Kessler contacted illustrator Whitney Sherman of Baltimore to create the artwork for the stamp. Directing the project, with feedback from a postal design advisory board, Kessler discussed themes with Sherman that the stamp should depict, such as strength and courage, and to show an ethnically vague woman. It was Sherman who came up with the solution of using Artemis, the Greek goddess of the hunt, protector of women, to symbolize the fight against breast cancer. The female hunter is depicted reaching for an arrow, to symbolize that she protects women from harm and to mimic the position women take during a breast exam. Sherman's illustration is a black line drawing of the female figure on a vibrant, abstract color field, done in pastel, which gives the stamp its optimistic or uplifting feel. Typographically, Kessler featured the phrases, "Fund the Fight" and "Find a Cure" outlining where the right breast should be.

On July 29, 1998, the Breast Cancer Research Stamp was issued at a White House event hosted by the First Lady Hillary Clinton with Postmaster General William Henderson, Senator Dianne Feinstein, Congressman Vic Fazio and Betsy Mullen.

The stamp originally cost 40 cents; [5] a regular first-class stamp cost 34 cents at that time. [6] 70 percent of funds raised are donated to the National Cancer Institute and 30 percent to the Breast Cancer Research Program of the Department of Defense. As of May 2006, US$35.2 million had been donated to the NCI and the Department of Defense had collected US$15.1 million. [7]

United States Senators Dianne Feinstein, Alfonse D'Amato and New York Congressman Vic Fazio who championed the Breast Cancer Research Stamp in Congress, calls the reauthorization of the BCR Stamp "good news in the fight against breast cancer." Originally set for a limited run, its release was extended numerous times by acts of the U.S. Congress with the most recent reauthorization legislation going through December 31, 2015. [8]

Since the Breast Cancer Research Stamp first went on sale on July 29, 1998 [9] through November 2011, the United States Postal Service has sold more than 924 million stamps, raising approximately $72 million for breast cancer research at the NIH and DoD. The Breast Cancer Research Stamp currently costs 75 cents and is deemed valid as a 58-cent first-class stamp. The additional 17 cents charged for each semipostal (fundraising) stamp is directed to research programs at the National Institutes of Health, which receives 70 percent of the net proceeds, and the Department of Defense breast cancer research programs, which receive the remaining 30 percent of the net proceeds.

The Breast Cancer Research Stamp is offered through the United States Postal Service as an alternative to a first-class postage stamp. Purchasing the stamp is a convenient and voluntary way to contribute to the fight against breast cancer. Congress passed "The Stamp Out Breast Cancer Act of 1997" and the BCR Stamp was first issued on July 29, 1998, becoming the country's first fundraising stamp.

In 2014 the stamp was reissued with that year's date below the "USA", rather than "1998" to the side, as shown above. Thus there are two varieties of the Breast Cancer Research Stamp, separately listed in the Scott catalogue as "B1" and "B5". Like some other stamps during the 2012-16 period, the Postal Service issued the 2014 stamp twice, both with and, less commonly, without a die cut. This made the latter an imperforated variety.

Programs supported

The funds generated by the Breast Cancer research Stamp have gone to researchers making significant advances in breast cancer research and have been used to fund research grants to support new, innovative programs. According to the National Institutes of Health, some of the programs the National Cancer Institute (NCI) has funded with proceeds from the stamp include the following: [10]

One of the Congressional research programs managed by the USAMRMC Office of Congressionally Directed Medical Research Programs (CDMRP) is the Breast Cancer Research Program (BCRP). As a result of the Stamp Out Breast Cancer Act, the DOD BCRP is one of two designated recipients of revenues from sales of the US Postal Service's Breast Cancer Stamp. The Stamp Out Breast Cancer Act (Public Law 105–41) resulted from the work of advocates for breast cancer research. This legislation led to the United States Postal Service's issuance of a new first-class stamp, the Breast Cancer Research Stamp, that can be purchased on a voluntary basis by the public.

Timeline

Since the Breast Cancer Research Stamp was first offered for sale in 1998 the DOD BCRP has received 30% from the sales of the US Postal Service's first class Breast Cancer Research Stamp (Public Law 105–41, Stamp Out Breast Cancer Act [H.R. 1585]), totalling $16,387,657.27.

Program accomplishments and outcomes

As Breast Cancer Research Stamp revenues become available to the CDMRP, the funds are applied to Idea Awards under negotiation at the time. In FY07, the stamp funds began funding Synergistic Idea Awards also. The DOD has fully funded 34 BCRP Idea Awards, partially funded 2 other Idea Awards as well as fully funded one Synergistic Idea Award and partially funded 2 others. The BCRP Idea Awards are intended to encourage innovative approaches to breast cancer research and are a backbone of the BCRP's portfolio of awards.

Many of the research projects supported by Breast Cancer Research Stamp funds are studying the changes in breast cells that result in the development of breast cancer from normal breast cells, focusing on understanding how and why breast cancer cells continue to grow and divide. Understanding these changes offers the opportunity to develop new drugs to prevent or treat breast cancer.

Metastasis is the spread of tumors to distant sites. Several of the Breast Cancer Research Stamp Awards are seeking to develop new drugs to prevent cancer progression and metastasis.

Risk is another approach to the study of breast cancer. Researchers supported by Breast Cancer Research Stamp funds assess risk by examining individuals or groups of people (populations) who are at risk of developing the disease.

The Breast Cancer Research Stamp funds also support two projects using nanotechnology. The ultimate goal of both projects is to use nanoparticles for the early detection of breast cancer.

Sales

Loganville, a small town in Georgia, started a campaign to increase sales of the Breast Cancer Research Stamp called "Contract to Cure Cancer". [11] This campaign succeeded in making the Loganville post office the number one seller per capita of the Breast Cancer Research Stamp.

Related Research Articles

<span class="mw-page-title-main">United States Postal Service</span> Independent agency of the U.S. federal government

The United States Postal Service (USPS), also known as the Post Office, U.S. Mail, or Postal Service, is an independent agency of the executive branch of the United States federal government responsible for providing postal service in the U.S., its insular areas, and its associated states. It is one of the few government agencies explicitly authorized by the Constitution of the United States. As of 2023, the USPS has 525,469 career employees and 114,623 non-career employees.

<span class="mw-page-title-main">Christmas seals</span> Labels (not stamps) placed on mail during Christmas

Christmas seals are adhesive labels that are similar in appearance to postage stamps that are sold then affixed to mail during the Christmas season to raise funds and awareness for charitable programs. Christmas seals have become particularly associated with lung diseases such as tuberculosis, and with child welfare in general. They were first issued in Denmark beginning in 1904, with Sweden and Iceland following with issues that same year. Thereafter the use of Christmas seals proved to be popular and spread quickly around the world, with 130 countries producing their own issues.

<span class="mw-page-title-main">Gary Miller (politician)</span> American politician (born 1948)

Gary Gene Miller is an American politician, who was the U.S. representative for California's 31st congressional district. A Republican, he was first elected in 1998 and served until 2015, when he retired. The district includes most of southern and western San Bernardino County. He previously represented the 42nd district from 1999 to 2013. In February 2014, Miller announced he would step down at the next election.

The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. The NCI conducts and supports research, training, health information dissemination, and other activities related to the causes, prevention, diagnosis, and treatment of cancer; the supportive care of cancer patients and their families; and cancer survivorship.

<span class="mw-page-title-main">History of United States postage rates</span>

The system for mail delivery in the United States has developed with the nation. Rates were based on the distance between sender and receiver in the early years of the nation. In the middle of the 19th century, rates stabilized to one price regardless of distance. Rates were relatively unchanged until 1968, when the price was increased every few years by a small amount. Comparing the increases with a price index, the price of a first class stamp has been steady. The seal of the Post Office Department showed a man on a running horse, even as railroads and, later, motorized trucks and airplanes moved mail. In 1971, the Post Office became the United States Postal Service, with rates set by the Postal Regulatory Commission, with some oversight by Congress. Air mail became standard in 1975. In the 21st century, prices were segmented to match the sorting machinery in use; non-standard letters required slightly higher postage.

<span class="mw-page-title-main">American Letter Mail Company</span> Defunct US company (1844–1851)

The American Letter Mail Company was started by Lysander Spooner in 1844, competing against the legal monopoly of the United States Post Office.

The Canadian Breast Cancer Foundation was a charitable organization which raised money to advance research, education, diagnosis and treatment of breast cancer. Established in 1986 by Nancy Tsai, it worked to fund, support, and advocate for education and awareness programs, early diagnosis and treatment of breast cancer, and quality of life for those suffering from breast cancer. It is also part of a seven-member coalition which funds breast cancer research in Canada.

<span class="mw-page-title-main">Canadian Cancer Society</span> Canadian charity

The Canadian Cancer Society is Canada's largest national cancer charity and the largest national charitable funder of cancer research in Canada.

<span class="mw-page-title-main">Mary Lasker</span> American health activist and philanthropist

Mary Woodard Lasker was an American health activist and philanthropist. She worked to raise funds for medical research and founded the Lasker Foundation.

Dartmouth Cancer Center (DCC) is a comprehensive cancer research center as designated by the National Cancer Institute. It is located at Dartmouth College and the Geisel School of Medicine in Hanover, New Hampshire. Its administrative offices are located within the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire.

A semi-postal stamp or semipostal stamp, also known as a charity stamp, is a postage stamp issued to raise money for a particular purpose and sold at a premium over the postal value. Typically the stamp shows two denominations separated by a plus sign, but in many cases the only denomination shown is for the postage rate, and the postal customer simply pays the higher price when purchasing the stamps.

<span class="mw-page-title-main">Non-denominated postage</span> Type of postage stamp

Non-denominated postage is a postage stamp intended to meet a certain postage rate, but printed without the denomination, the price for that rate. They may retain full validity for the intended rate, regardless of later rate changes, or they may retain validity only for the original purchase price. In many English-speaking countries, it is called non-value indicator or non-value indicated (NVI) postage. Introduced to reduce the cost of printing large issues of low-value stamps to "top-up" old issues, NVI stamps are used in many countries.

The "war on cancer" is the effort to find a cure for cancer by increased research to improve the understanding of cancer biology and the development of more effective cancer treatments, such as targeted drug therapies. The aim of such efforts is to eradicate cancer as a major cause of death. The signing of the National Cancer Act of 1971 by United States president Richard Nixon is generally viewed as the beginning of this effort, though it was not described as a "war" in the legislation itself.

<span class="mw-page-title-main">Breast Cancer Research Foundation</span> Research organization

The Breast Cancer Research Foundation (BCRF) is an independent, not-for-profit organization which has raised $569.4 million to support clinical and translational research on breast cancer at medical institutions in the United States and abroad. BCRF currently funds over 255 researchers in 14 countries.

<span class="mw-page-title-main">Political positions of Dianne Feinstein</span> Full coverage of the policies of a US politician

Dianne Feinstein was the senior senator representing California in the U.S. Senate. A Democrat, she served in the Senate from 1992 to 2023. Prior to her Senate tenure, Feinstein ran for Governor of California and served as Mayor of San Francisco.

The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) is a National Cancer Institute (NCI)-designated comprehensive cancer center located in Baltimore, Maryland.

<span class="mw-page-title-main">John E. Niederhuber</span>

John E. Niederhuber was the 13th director of the National Cancer Institute (NCI), from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime. A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and co-director, Johns Hopkins Clinical Research Network.

Ovarian Cancer Research Alliance (OCRA) is a not-for-profit organization focused on ovarian cancer research, advocacy and patient support. The organization was formed in January 2016 when the former not-for-profit organization Ovarian Cancer Research Fund, which focused primarily on ovarian cancer research, combined with Ovarian Cancer National Alliance, which focused primarily on ovarian cancer advocacy and support programs, to form one organization.

<span class="mw-page-title-main">Gretchen Gierach</span> American epidemiologist

Gretchen L. Gierach is an American epidemiologist and women's health researcher. She is the chief of the Integrative Tumor Epidemiology Branch in the National Cancer Institute.

References

  1. King, Samantha (2006). Pink Ribbons, Inc.: Breast Cancer and the Politics of Philanthropy . Minneapolis: University of Minnesota Press. p.  65. ISBN   0-8166-4898-0.
  2. The following year Dr. Bodai sent out correspondence to 200 breast cancer organizations looking for support. Shelly Blechman, Vice President of Women's Information Network Against Breast Cancer (WIN ABC), was the only one to respond and a partnership begin. Dr. Bodai, along with breast cancer survivor and advocate (founder/CEO of WIN ABC) Elizabeth ("Betsy") Mullen and David Goodman who lost his first wife to breast cancer, in close collaboration with United States Senator Dianne Feinstein, Congressman Vic Fazio and their colleagues in Congress to spearhead the national grassroots advocacy efforts that led to the creation and issuance of the Breast Cancer Research Stamp. Interview and article in the Permanente Journal Archived June 13, 2006, at the Wayback Machine
  3. "Fact Sheet: Breast Cancer Research Semipostal Program; Congressionally Directed Medical Research Programs (CDMRP)". Archived from the original on 2008-06-12. Retrieved 2008-10-24. and http://cdmrp.army.mil/pubs/pips/bcstamppip.pdf
  4. "The Breast Cancer Research semipostal" . Retrieved 2007-09-05.[ dead link ]
  5. "U.S. Postal Service To Revalue Breast Cancer Research Semipostal". USPS. 2002-03-21. Archived from the original on 2010-08-21. Retrieved 2010-05-24.
  6. "Stamping Out Breast Cancer". snopes.com. 2008-01-03. Retrieved 2010-05-24.
  7. "Fact Sheet: Breast Cancer Research Semipostal Program; Congressionally Directed Medical Research Programs (CDMRP)". Cdmrp.army.mil. Archived from the original on June 12, 2008. Retrieved 2008-10-24.
  8. "Breast Cancer Research Semipostal Stamps to Remain on Sale through December 31, 2015". United States Postal Service. 2012-01-26. Retrieved 2013-03-20.
  9. "Fundraising Stamps (Semipostal Stamp Program)". United States Postal Service. 2013. Retrieved 2013-03-20.
  10. "Office of Budget and Finance (OBF) - National Cancer Institute". 5 December 2014.
  11. "Contract To Cure Cancer". Contracttocurecancer.com. Retrieved 2008-10-24.